(Q38879405)

English

Morbidity due to Schistosoma mansoni: an epidemiological assessment of distended abdomen syndrome in Ugandan school children with observations before and 1-year after anthelminthic chemotherapy

scientific article published on 12 June 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

7 September 2017

Morbidity due to Schistosoma mansoni: an epidemiological assessment of distended abdomen syndrome in Ugandan school children with observations before and 1-year after anthelminthic chemotherapy (English)

1 reference

Europe PubMed Central

7 September 2017

0 references

Schistosoma mansoni

0 references

8

object named as

Jürg Utzinger

0 references

Narcis B Kabatereine

3

object named as

Narcis B Kabatereine

1 reference

Europe PubMed Central

7 September 2017

Edridah M Tukahebwa

4

object named as

Edridah M Tukahebwa

0 references

object named as

Julie Balen

1

0 references

9

object named as

Alan Fenwick

1 reference

Europe PubMed Central

7 September 2017

Joanne P. Webster

object named as

Joanne P Webster

7

0 references

author name string

J Russell Stothard

2

1 reference

Europe PubMed Central

7 September 2017

Edridah M Tukahebwa

4

1 reference

Europe PubMed Central

7 September 2017

Francis Kazibwe

5

1 reference

Europe PubMed Central

7 September 2017

Sarah Whawell

6

1 reference

Europe PubMed Central

7 September 2017

publication date

12 June 2006

1 reference

Europe PubMed Central

7 September 2017

Transactions of the Royal Society of Tropical Medicine and Hygiene

1 reference

Europe PubMed Central

7 September 2017

100

1 reference

Europe PubMed Central

7 September 2017

11

1 reference

Europe PubMed Central

7 September 2017

1039-1048

1 reference

Europe PubMed Central

7 September 2017

The impact of host genetics on susceptibility to human infectious diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.12.013

7 January 2021

[A foci of Schistosomiasis mekongi rediscovered in Northeast Cambodia: cultural perception of the illness; description and clinical observation of 20 severe cases]

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.12.013

7 January 2021

Reversibility of Schistosoma mansoni-associated morbidity after yearly mass praziquantel therapy: ultrasonographic assessment.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.12.013

7 January 2021

Geographic differences in hepatosplenic complications of schistosomiasis mansoni and explanatory factors of morbidity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.12.013

7 January 2021

Hepatosplenic morbidity in two neighbouring communities in Uganda with high levels of Schistosoma mansoni infection but very different durations of residence

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.12.013

7 January 2021

Periportal fibrosis in human Schistosoma mansoni infection is associated with low IL-10, low IFN-gamma, high TNF-alpha, or low RANTES, depending on age and gender

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.12.013

7 January 2021

Evaluating the epidemiological impact of national control programmes for helminths

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.12.013

7 January 2021

The global epidemiological situation of schistosomiasis and new approaches to control and research

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.12.013

7 January 2021

Drugs for the control of parasitic diseases: current status and development in schistosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.12.013

7 January 2021

The use of ultrasound in schistosomiasis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.12.013

7 January 2021

Epidemiology and geography of Schistosoma mansoni in Uganda: implications for planning control

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.12.013

7 January 2021

Epidemiology and morbidity of Schistosoma mansoni infection in a fishing community along Lake Albert in Uganda

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.12.013

7 January 2021

Progress towards countrywide control of schistosomiasis and soil-transmitted helminthiasis in Uganda

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.12.013

7 January 2021

Measuring morbidity in schistosomiasis mansoni: relationship between image pattern, portal vein diameter and portal branch thickness in large-scale surveys using new WHO coding guidelines for ultrasound in schistosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.12.013

7 January 2021

Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.12.013

7 January 2021

The unreliability of the Kato-Katz technique limits its usefulness for evaluating S. mansoni infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.12.013

7 January 2021

Schistosoma mansoni: assessment of morbidity before and after control

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.12.013

7 January 2021

The WHO dose pole for the administration of praziquantel is also accurate in non-African populations

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.12.013

7 January 2021

Associations between anti-Schistosoma mansoni and anti-Plasmodium falciparum antibody responses and hepatosplenomegaly, in Kenyan schoolchildren.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.12.013

7 January 2021

The use and limitations of ultrasonography in the diagnosis of liver morbidity attributable to Schistosoma mansoni infection in community-based surveys

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.12.013

7 January 2021

The contribution of hookworm and other parasitic infections to haemoglobin and iron status among children and adults in western Kenya.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.12.013

7 January 2021

The epidemiology and consequences of Schistosoma mansoni infection in West Nile, Uganda. I. Field studies of a community at Panyagoro

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.12.013

7 January 2021

The epidemiology and consequences of Schistosoma mansoni infection in West Nile, Uganda II. Hospital investigation of a sample from the Panyagoro community

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.12.013

7 January 2021

Disparities in parasitic infections, perceived ill health and access to health care among poorer and less poor schoolchildren of rural Côte d'Ivoire

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.12.013

7 January 2021

Schistosomiasis mansoni in low transmission areas: abdominal ultrasound.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.12.013

7 January 2021

Schistosomiasis and soil-transmitted helminthiasis: common drugs for treatment and control

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.12.013

7 January 2021

Associating community prevalence of Schistosoma mansoni infection with prevalence of signs and symptoms

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.12.013

7 January 2021

Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.12.013

7 January 2021

Morbidity in schistosomiasis: an update

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.12.013

7 January 2021

Regression of hepatosplenomegaly in Kenyan school-aged children after praziquantel treatment and three years of greatly reduced exposure to Schistosoma mansoni

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.12.013

7 January 2021

Metabonomic investigations in mice infected with Schistosoma mansoni: an approach for biomarker identification

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.12.013

7 January 2021

Identifiers

10.1016/J.TRSTMH.2005.12.013

1 reference

Europe PubMed Central

7 September 2017

1 reference

Europe PubMed Central

7 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38879405&oldid=1970271754"